HEDS will be at ISPOR Europe in full strength between the 10-14th November in Barcelona delivering a variety of sessions. Below you can see a summary (with links) to all of HEDS workshops and talks at the conference.
CC BY 2.0 Rodrigo Paredes http://bit.ly/2zyWvIO |
Saturday 10th November
- Development of Conceptual Models, Paul Tappenden, Saturday 10th November 2018; 8:00AM – 12:00PM
- Introduction to Constrained Optimization Methods for Health Care Research, Praveen Thokala, Saturday 10th November 2018; 8:00AM – 12:00PM
Sunday 11th November
- Mapping to Estimate Utility Values from Non-Preference Based Outcome Measures, Allan Wailoo and Monica Hernandez, Sunday 11th November 2018; 8:00AM – 12:00PM
- Adjusting for Time-Dependent Confounding and Treatment Switching Bias in Observational Studies and Clinical Trials: Purpose, Methods, Good Practices and Acceptance in HTA, Nick Latimer, Sunday 11th November 2018; 1:00PM – 5:00PM
Monday 12th November
- PIH52: An Investigation Into The Content Validity And Feasibility Of The EQ-5D-5L, SF-12, WEMWBS And ONS-4 In Measuring The Quality Of Life And Wellbeing Of Older Adults., Hannah Penton, Monday 12th November 2018; 8:45AM -1:45PM
- Measuring Quality Of Life For Economic Evaluation In Duchenne Muscular Dystrophy (DMD) From Childhood To Adulthood: Protocol For A New Preference-Based Measure, John Brazier, Monday 12th November 2018; Poster Author Discussion Hour: 12:45PM – 1:45PM
- Quantifying Worldwide Evidence To Estimate The Risk Of Transmitting Creutzfeldt-Jakob Disease Via Surgical Procedures, Lesley Uttley, Monday 12th November 2018; Poster Author Discussion Hour: 12:45PM – 1:45PM
- W3: Adjusting For Postrandomization Confounding And Switching In Phase III And Pragmatic Trials To Get The Estimands Right: Needs, Methods, Sub-Optimal Use, And Acceptance In HTA, Nick Latimer, Monday 12th November 2018; 2:15PM – 3:15PM
- F7: Health State Utility (HSU) Good Practices Task Force Recommendations For Identification And Use Of Hsu Data In Cost-Effectiveness In Decision Modelling, John Brazier and Suzy Paisley, Monday 12th November 2018; 6:15PM – 7:15PM
Tuesday 13th November
- Eliciting Public Preferences For Reorganization Of Vascular Services In The UK, Nyantara Wickramasekera, Tuesday 13th November 2018; 3:30PM – 7:00PM
- Methods Used To Identify Patient Reported Outcome Measures In Vascular Diseases, Munira Essat, Tuesday 13th November 2018; Poster Author Discussion Hour: 6:00PM – 7:00PM
Wednesday 14th November
- W17: Estimating Comparative Effectiveness In The Presence Of Treatment Switching And Delayed Initiation (And Other Real-World Data Challenges!), Nick Latimer, Wednesday 14th November 2018; 8:45AM – 9:45AM
- The Cancer Drugs Fund: Key Uncertainties, Data Collection Plans, Analytical Methods And Use Of The Systematic Anti-Cancer Therapy (SACT) Real World Data Set, Nick Latimer, Tuesday 13th November 2018; 3:30PM – 7:00PM